- Artificial saliva, formulated to mimic natural saliva and provide moisture and lubrication in the oral cavity, plays a crucial role in managing xerostomia caused by conditions such as Sjögren’s syndrome, radiation therapy, or medication side effects. Its use is vital in improving patient comfort, oral health, and overall quality of life
- The growing incidence of dry mouth, especially among the elderly and cancer patients, coupled with increasing awareness of oral health management, is significantly driving the demand for artificial saliva products globally
- North America dominated the artificial saliva market with the largest revenue share of 39.2% in 2024, characterized by a well-established healthcare infrastructure, rising geriatric population, and greater adoption of supportive care products, especially in the U.S., where dry mouth is a common side effect of prescription medications and cancer therapies
- Asia-Pacific is expected to be the fastest growing region in the artificial saliva market during the forecast period due to improving healthcare access, growing medical expenditure, and increased awareness of xerostomia treatment options in countries such as China, India, and Japan
- Gel segment dominated the artificial saliva market with a market share of 42% in 2024, driven by its longer-lasting moisture retention and ease of use, especially among patients with severe dry mouth or limited manual dexterity
